Vimarsana
Biggest News Aggregation in the World

Greg Delgoffe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Delgoffe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Delgoffe Today - Breaking & Trending Today

Cancer-infecting virus warms up cold tumors, boosts immunotherapy: Research - Vimarsana News

Cancer-infecting virus warms up cold tumors, boosts immunotherapy: Research

The study states that cancer-infecting viruses can boost immunity of the body and support immunotherapy.  | Health

Oncolytic viruses could be used to 'warm up' cold tumors and improve immunotherapy - Vimarsana News

Oncolytic viruses could be used to 'warm up' cold tumors and improve immunotherapy

Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice, according to a new study in the Journal of Experimental Medicine led by University of Pittsburgh and UPMC researchers.

KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards - Vimarsana News

KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards

KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards - read this article along with other careers information, tips and advice on BioSpace

KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards - Vimarsana News

KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards

/PRNewswire/ -- KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today...

Terminally exhausted T cells may remain competent for transcription, researchers say - Vimarsana News

Terminally exhausted T cells may remain competent for transcription, researchers say

During a battle with cancer, T cells can become exhausted and are no longer able to function properly. The early phase of exhaustion can sometimes be reversed with immunotherapy drugs, but once T cells become too exhausted, it had been thought that this state was irreversible. However, new insights from University of Pittsburgh and UPMC researchers suggest that even the most fatigued T cells can be revived.